Materiały źródłowe

• #1

  https://www.nhs.uk/conditions/rickets-and-osteomalacia/treatment/

  As most cases of rickets are caused by a vitamin D and calcium deficiency, it’s usually treated by increasing a child’s intake of vitamin D and calcium. […] Vitamin D and calcium levels can be increased by: […] Your GP will advise you about how much vitamin D and calcium your child will need to take. This will depend on their age and the cause of rickets. If your child has problems absorbing vitamins, they may need a higher dose. […] When rickets occurs as a complication of another medical condition, treating the underlying condition will often cure the rickets. […] If your child has a bone deformity caused by rickets, such as bowed legs or curvature of the spine, your GP may suggest treatment to correct it. This may include surgery. […] A combination of phosphate supplements and a special form of vitamin D is required for the treatment of hypophosphatemic rickets, where a genetic defect causes abnormalities in the way the kidneys and bones deal with phosphate.

• #1 Rickets – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/rickets/diagnosis-treatment/drc-20351949

  Most cases of rickets can be treated with vitamin D and calcium supplements. Follow the directions as to dosage. Too much vitamin D can be harmful. […] Your child’s healthcare team may check your child’s progress with X-rays and blood tests. […] If your child has a rare inherited disorder that causes low amounts of phosphorus, supplements and medicines may be prescribed. […] For some cases of bowleg or spinal deformities, your healthcare professional might suggest special bracing to position your child’s body properly as the bones grow. More-serious skeletal deformities might require surgery.

• #1

  https://link.springer.com/article/10.1007/s11914-017-0383-y

  Nutritional rickets and osteomalacia are common in dark-skinned and migrant populations. […] For rickets prevention, 400 IU daily is recommended for all infants from birth and 600 IU in pregnancy, alongside monitoring in antenatal and child health surveillance programmes. […] High-risk populations require lifelong supplementation and food fortification with vitamin D or calcium. […] The Global Consensus group recommended doses of vitamin D and calcium for treatment of NR. […] All children with NR should be treated with vitamin D for a minimum of 3 months with a daily dose of at least 2000 IU (50 g) if aged 12 months, 3000-6000 IU (50-150 g) if aged 12 months-12 years, and 6000 IU (150 g) if aged 12 years. […] All individuals should also receive concomitant calcium (minimum 500 mg/day) as supplements or via diet.

• #1 Rickets Treatment & Management: Approach Considerations, Deterrence/Prevention

  https://emedicine.medscape.com/article/985510-treatment

  Treatment for rickets may be administered gradually over several months or in a single-day dose of 15,000 mcg (600,000 U) of vitamin D. […] If the gradual method is chosen, 125-250 mcg (5000-10,000 U) is given daily for 2-3 months until healing is well established and the alkaline phosphatase concentration is approaching the reference range. […] If the vitamin D dose is administered in a single day, it is usually divided into 4 or 6 oral doses. […] The single-day therapy avoids problems with compliance and may be helpful in differentiating nutritional rickets from familial hypophosphatemia rickets (FHR). […] A study by Dabas et al compared the efficacy of daily versus weekly oral vitamin D3 therapy in the radiologic healing of nutritional rickets. […] A study by Thacher et al sought to determine the optimal dose of calcium for treatment of children with rickets. […] If severe deformities have occurred, orthopedic correction may be required after healing. […] A consultation with a pediatric endocrinologist is recommended.

• #1

  https://link.springer.com/article/10.1007/s00467-022-05505-5

  Thus, in XLH patients on conventional treatment, improvement/normalization of serum ALP is the main biochemical surrogate indicating adequate treatment. […] By contrast, burosumab treatment is primarily tailored according to fasting serum phosphate levels, which should be kept in the lower age-related normal range. […] The primary treatment goal is to correct or at least improve rickets/osteomalacia based on clinical and biochemical parameters. […] Patients should be treated with ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) at a minimal dose of 2000 IU (50 g) per day in conjunction with 500 mg oral calcium per day, either as a dietary intake or supplements, for a minimum of 3 months. […] The duration of therapy should be individually tailored, based on treatment response. Combined treatment is recommended, as the diet of children and adolescents with nutritional rickets is usually low in both vitamin D and calcium.

• #1 Nutritional rickets & osteomalacia: A practical approach to management

  https://pmc.ncbi.nlm.nih.gov/articles/PMC8061584/

  A minimum of 12 wk treatment is recommended; nonetheless, the duration should be tailored to the individual based on the response to treatment. […] Calcium (intravenous or oral) is used in the management of children presenting with acute hypocalcaemic complications such as seizures or heart failure. […] There is absolutely no role for phosphate supplements in the treatment of nutritional rickets; in fact, giving phosphate worsens secondary hyperparathyroidism. […] Reversal of secondary hyperparathyroidism with vitamin D/calcium supplementation improves serum phosphate levels. […] Screening of other family members is crucial to address the hidden crisis. […] A crucial step in the prevention of nutritional rickets worldwide is robust vitamin D supplementation in pregnancy and infancy.

• #1 Rickets | Better Health Channel

  https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/rickets

  Rickets is usually caused by a lack of vitamin D, calcium or phosphorus. […] Treatment options include improved sunlight exposure, diet, vitamin D and mineral supplements. […] Treatment options for rickets include: improved sunlight exposure, improved diet that includes adequate intake of calcium and vitamin D, oral vitamin D supplements these may need to be taken for about 3 months, special forms of vitamin D supplements for people whose bodies cant convert vitamin D into its active form, treatment for any underlying disorder, surgery to correct severe bone deformities. […] Bones that are poorly mineralised generally respond very quickly to dietary supplementation with calcium and vitamin D. Improvements may be seen on x-ray after only a few days of treatment. If rickets is treated when the child is young, there is a good chance that the skeletal deformities will disappear as the child matures. However, the deformities and reduced height will be permanent if the child goes through puberty without treatment.

• #1

  https://link.springer.com/article/10.1007/s11914-017-0383-y

  All treatment should be followed by lifelong vitamin D supplements, since the underlying risk (ethnicity, culture and sunlight exposure) is unlikely to change. […] NR and osteomalacia are fully preventable. […] The global consensus recommends the following vitamin D supplements for prevention of NR and osteomalacia: 400 IU (10 g) daily for all infants regardless of mode of feeding, from birth to a minimum of 12 months of age; 600 IU (15 g) daily during pregnancy; 600 IU daily lifelong in risk groups.

• #1

  https://www.nhs.uk/conditions/rickets-and-osteomalacia/treatment/

  Children with other types of genetic rickets need very large amounts of a special type of vitamin D treatment. […] If you have osteomalacia the adult form of rickets that causes soft bones treatment with supplements will usually cure the condition. […] You should continue taking vitamin D supplements regularly to prevent the condition returning.

• #1 Frontiers | Diagnosis, treatment, and management of rickets: a position statement from the Bone and Mineral Metabolism Group of the Italian Society of Pediatric Endocrinology and Diabetology

  https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1383681/full

  Administration of a single-day high-dose of vitamin D therapy (stoss therapy), with doses reaching up to 600,000 IU, has been proposed. […] Daily treatment with vitamin D should be continued for 3-4 months, but the duration of treatment should be individualized. […] Patients experiencing symptomatic hypocalcemia, such as tetany, convulsions, or dilated cardiomyopathy, should receive intravenous calcium gluconate until serum calcium levels are normalized. […] Monitoring of treatment with vitamin D and calcium supplements varies with the severity of rickets and response to therapy. […] In order to prevent the resurgence of nutritional vitamin D deficiency rickets vitamin D supplementation should be continued. […] The recommended daily oral intake of calcium and phosphate varies between 150-220 mg/kg/day and 75-140 mg/kg/day through enteral feeds, respectively.

• #1

  https://journals.lww.com/ijmr/fulltext/2020/52040/nutritional_rickets___osteomalacia__a_practical.6.aspx

  Both D2 and D3 can be used for daily oral supplementation, however D3 is preferred for stoss therapy i.e., a single high-dose treatment, due to its longer half-life. […] A recent report of all the vitamin D supplements available in the Indian market highlighted the lack of suitable preparations. […] Dilated cardiomyopathy is generally treated with a combination of diuretics and angiotensin-converting enzyme inhibitors but must be managed in conjunction with a paediatric cardiologist.

• #1 Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia | Nature Reviews Nephrology

  https://www.nature.com/articles/s41581-019-0152-5

  Treatment with phosphate and/or active vitamin D does not decrease or prevent the development of osteoarthritis or enthesopathies. […] Currently, evidence that treatment with burosumab ameliorates these complications is lacking. […] Recommendations for conventional treatment in children with XLH are provided in Box 3. Oral phosphate supplements should always be provided together with active vitamin D, as phosphate alone promotes secondary hyperparathyroidism and thereby renal phosphate wasting. […] We recommend treating children with overt X-linked hypophosphataemia (XLH) phenotype with a combination of oral phosphorus (phosphate salts) and active vitamin D (calcitriol or alfacalcidol) as soon as diagnosis is established. […] We recommend an initial dose of 20-60 mg/kg body weight daily (0.7-2.0 mmol/kg daily) of elemental phosphorus in infants and preschool children, which should be adjusted according to the improvement of rickets, growth, alkaline phosphatase (ALP) and parathyroid hormone (PTH) levels.

• #1

  https://link.springer.com/article/10.1007/s00467-022-05505-5

  Treatment with phosphate should always be done in combination with active vitamin D (either with calcitriol or alphacalcidiol) in XLH patients, as this prevents the development of secondary hyperparathyroidism as seen in patients treated with phosphate salts alone, which further promotes renal phosphate wasting and can result in autonomous (tertiary) hyperparathyroidism. […] Treatment with active vitamin D also improves remineralization of the skeleton by enhancing vitamin D-dependent intestinal calcium and phosphate absorption. […] Burosumab has been approved by the European Medicines Agency (EMA), the US Food and Drug Administration (FDA), and Japanese health authorities for treatment of pediatric XLH patients aged above 12 months (6 months in the USA), showing radiographic evidence of bone disease and with growing skeletons.

• #1 Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia | Nature Reviews Nephrology

  https://www.nature.com/articles/s41581-019-0152-5

  We recommend treatment in symptomatic adults with X-linked hypophosphataemia (XLH) by active vitamin D together with oral phosphorus (phosphate salts) to reduce osteomalacia and its consequences and to improve oral health. […] We do not recommend routine treatment of asymptomatic adults with XLH. […] We recommend using substantially lower doses of active vitamin D and oral phosphate than are used in children.

• #1 Hypophosphatemic Rickets – Pediatrics – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/pediatrics/congenital-renal-transport-abnormalities/hypophosphatemic-rickets

  Treatment is oral phosphate plus calcitriol; burosumab is given for X-linked hypophosphatemia. […] Treatment of hypophosphatemic rickets consists of neutral phosphate solution or tablets. Phosphate supplementation lowers ionized calcium concentrations and further inhibits calcitriol conversion, leading to secondary hyperparathyroidism and exacerbating urinary phosphate wasting. Therefore, oral vitamin D is given as calcitriol. However, in HHRH or HHN (hypophosphatemia, hypercalcemia, and nephrocalcinosis), 1,25-dihydroxyvitamin D3 levels are elevated and dosing with calcitriol can be detrimental. […] Burosumab is an anti-FGF-23 monoclonal antibody that has become the treatment of choice for X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO) and has replaced the conventional therapy described above. The dose may be titrated upwards as needed to normalize serum phosphate. […] Treat with oral phosphate supplements and, except for HHRH and HHN (hypophosphatemia, hypercalcemia, and nephrocalcinosis), vitamin D (given as calcitriol). Use burosumab for appropriate patients with X-linked hypophosphatemia and tumor-induced osteomalacia.

• #1

  https://link.springer.com/article/10.1007/s00467-022-05505-5

  The recommended starting dose of burosumab in children amounts to 0.8 mg/kg body weight. It should be given in 2-weekly intervals as subcutaneous injections. […] As an alternative to conventional treatment, patients can also be treated very effectively with burosumab which was recently approved for treatment of TIO in children and adults by the FDA and the Japanese health authorities based on clinical trials in adult patients.

• #1 FGF23-related hypophosphatemic rickets/osteomalacia: diagnosis and new treatment in: Journal of Molecular Endocrinology Volume 66 Issue 2 (2021)

  https://jme.bioscientifica.com/view/journals/jme/66/2/JME-20-0089.xml

  In a phase 1 clinical trial, single injection or infusion of burosumab increased serum phosphate and 1,25(OH)2D in a dose-dependent manner in 38 adult patients with XLH. Subsequent phase 1/2 study indicated that s.c. injections of burosumab every 4 weeks induced prolonged increase in serum phosphate and 1,25(OH)2D for more than 1 year in adult patients with XLH. Safety profiles were favorable and the most common drug-related adverse event was the injection site reaction. Phase 2 study in children with XLHR indicated that burosumab increased serum phosphate and 1,25(OH)2D and induced radiographic improvement of rickets. This study showed that every 2 weeks injections were more effective than every 4 weeks dosings in child patients. Phase 3 study in child patients indicated that burosumab was more effective than conventional therapy with phosphate and active vitamin D in increasing serum phosphate, TmP/GFR and 1,25(OH)2D, decreasing alkaline phosphatase, improving radiographic findings of rickets, and increasing recumbent length and standing height Z score. Phase 3 trial in adult patients with XLH indicated that burosumab improved bone mineralization, WOMAC physical function and stiffness scores, and induced fracture healing more effectively than placebo. Burosumab was also shown to increase serum phosphate and 1,25(OH)2D and improve osteomalacia in patients with TIO. From these results, burosumab was approved for patients with XLH or XLHR since 2018 in several countries including Europe and USA. The approval of burosumab is now expanding to other countries in Asia, South America and Middle East. The indication of burosumab is different depending on countries. In addition to XLH or XLHR, burosumab is approved for patients with TIO in several countries and for patients with FGF23-related hypophosphatemic diseases in Japan.

• #1 Clinical trial at IU School of Medicine improves treatment of genetic rickets

  https://medicine.iu.edu/news/2019/05/clinical-trial-at-iu-school-of-medicine-improves-treatment-of-genetic-rickets

  A new study shows a drug developed in conjunction with investigators at Indiana University School of Medicine to alleviate symptoms of a rare musculoskeletal condition is significantly more effective than conventional therapies. […] The primary outcome was improvement in rickets on X-rays, as scored by radiologists that were unaware of which treatment group the participant was in. […] By 40 weeks of treatment, researchers found 72 percent of the children who received Burosumab achieved substantial healing of rickets, while only 6 percent of those in the conventional therapy group saw substantial healing. […] This is the first study comparing Burosumab head-to-head with conventional therapy, said lead investigator Erik Imel, MD, associate professor of medicine at IU School of Medicine. We now know the magnitude of benefit from Burosumab over the prior approach with conventional therapy. This information is critical for doctors to make treatment decisions for patients with XLH. […] Researchers plan to continue studying the long-term effects of Burosumab, including the effect treating children has on height outcomes as an adult and whether this treatment will decrease the need for surgeries to correct bowed legs.

• #1

  https://link.springer.com/article/10.1007/s00467-022-05505-5

  Here, we discuss the management of different forms of rickets, including new therapeutic approaches based on recent guidelines. Management includes close monitoring of growth, the degree of leg bowing, bone pain, serum phosphate, calcium, alkaline phosphatase as a surrogate marker of osteoblast activity and thus degree of rickets, parathyroid hormone, 25-hydroxyvitamin D3, and calciuria. An adequate calcium intake and normal 25-hydroxyvitamin D3 levels should be assured in all patients. Children with calcipenic rickets require the supplementation or pharmacological treatment with native or active vitamin D depending on the underlying pathophysiology. Treatment of phosphopenic rickets depends on the underlying pathophysiology. Fibroblast-growth factor 23 (FGF23)-associated hypophosphatemic rickets was historically treated with frequent doses of oral phosphate salts in combination with active vitamin D, whereas tumor-induced osteomalacia (TIO) should primarily undergo tumor resection, if possible. Burosumab, a fully humanized FGF23-antibody, was recently approved for treatment of X-linked hypophosphatemia (XLH) and TIO and shown to be superior for treatment of XLH compared to conventional treatment. Forms of hypophosphatemic rickets independent of FGF23 due to genetic defects of renal tubular phosphate reabsorption are treated with oral phosphate only, since they are associated with excessive 1,25-dihydroxyvitamin D production. Finally, forms of hypophosphatemic rickets caused by Fanconi syndrome, such as nephropathic cystinosis and Dent disease require disease-specific treatment in addition to phosphate supplements and active vitamin D. Adjustment of medication should be done with consideration of treatment-associated side effects, including diarrhea, gastrointestinal discomfort, hypercalciuria, secondary hyperparathyroidism, and development of nephrocalcinosis or nephrolithiasis.

• #1 Rickets: Definition, Symptoms, Causes & Treatment

  https://my.clevelandclinic.org/health/diseases/22459-rickets

  Surgery. Usually, your child’s bones will straighten out on their own. For especially severe cases, children may need to wear braces to help correct the bending of their bones. In some cases, surgery may also be an option. […] For inherited cases of rickets, there are several treatment options depending on the genetic disorder in question. Your pediatrician may refer you to see a specialist to help find a treatment solution.

• #1 Rickets – Wikipedia

  https://en.wikipedia.org/wiki/Rickets

  Sufficient vitamin D levels can also be achieved through dietary supplementation and/or exposure to sunlight. Vitamin D3 (cholecalciferol) is the preferred form since it is more readily absorbed than vitamin D2. […] Occasionally surgery is needed to correct severe and persistent deformities of the lower limbs, especially around the knees namely genu varum and genu valgum. Surgical correction of rachitic deformities can be achieved through osteotomies or guided growth surgery. Guided growth surgery has almost replaced the use of corrective osteotomies. The functional results of guided growth surgery in children with rickets are satisfactory. While bone osteotomies work through acute/immediate correction of the limb deformity, guided growth works through gradual correction.

• #1 Vitamin D Deficiency including Osteomalacia and Rickets

  https://patient.info/doctor/vitamin-d-deficiency-including-osteomalacia-and-rickets-pro

  Ensure maintenance therapy of vitamin D equivalent to 800-2000 IU daily (up to a maximum of 4000 IU daily for certain conditions such as malabsorption following specialist advice), given either daily or intermittently at a higher equivalent dose. […] If rapid correction of vitamin D deficiency is needed, a fixed loading dose is given for 8-12 weeks, followed by regular maintenance vitamin D therapy one month after loading. […] There is need for long-term maintenance vitamin D supplements, unless there is a significant lifestyle change to improve vitamin D status. […] Arrange follow-up for people with vitamin D deficiency to reassess serum calcium and vitamin D levels (if clinically indicated), and to check for ongoing symptoms. […] Once vitamin D deficiency has been treated, prevention is required to prevent recurrence. This includes correction of any underlying cause, lifestyle advice (diet, sunshine) and often long-term vitamin D supplements.

• #1 Nutritional rickets & osteomalacia: A practical approach to management – PubMed

  https://pubmed.ncbi.nlm.nih.gov/33380700/

  Defective mineralization of the growth plate and preformed osteoid result in rickets and osteomalacia, respectively. […] Treatment includes high-dose cholecalciferol or ergocalciferol daily for a minimum of 12 wk or stoss therapy in exceptional circumstances, each followed by lifelong maintenance supplementation. In addition, adequate calcium intake through diet or supplementation should be ensured. […] Preventative approaches should be tailored to the population needs and incorporate multiple strategies including targeted vitamin D supplementation of at-risk groups and food fortification with vitamin D and/or calcium. Economically, food fortification is certainly the most cost-effective way forward.

• #1 Rickets / Osteomalacia | Infonet Biovision Home.

  https://infonet-biovision.org/nutrition-related-diseases/rickets-osteomalacia

  Rickets is the softening of the bones in children, potentially leading to fractures and deformity. […] Osteomalacia is the term used to describe a similar condition occurring in adults, generally due to a deficiency of Vitamin D. […] The principal function of Vitamin D is to maintain serum calcium and phosphorus concentration within the range that supports neuromuscular function, bone calcification and other cellular processes. […] Use of supplements: vitamin D and calcium can be given as dietary supplements. […] Diet rich in vitamin D and calcium. […] For bone deformities such as bowlegs and some spinal deformities, braces may be used but in severe cases, surgery may be required. […] The majority of non-severe cases of both rickets and osteomalacia respond well to treatment and improvement is seen within 3-6 months. […] With adequate treatment and follow up, most individuals lead normal lives.

• #1 Rickets: Symptoms, Diagnosis, and Treatments

  https://www.healthline.com/health/rickets

  Increasing vitamin D, calcium, and phosphate levels will help correct the disorder. Most children with rickets see improvements in about one week. […] Skeletal deformities will often improve or disappear over time if rickets is corrected while the child is still young. However, skeletal deformities can become permanent if the disorder isnt treated during a childs growth period.

• #1 Rickets and osteomalacia – Treatment | Health Information from Marsden Pharmacy

  https://marsdenpharmacy.co.uk/nhs_conditions_rickets-and-osteomalacia_treatment

  If your child has a bone deformity caused by rickets, such as bowed legs or curvature of the spine, your GP may suggest treatment to correct it. This may include surgery. […] A combination of phosphate supplements and a special form of vitamin D is required for the treatment of hypophosphatemic rickets, where a genetic defect causes abnormalities in the way the kidneys and bones deal with phosphate. […] Children with other types of genetic rickets need very large amounts of a special type of vitamin D treatment. […] If you have osteomalacia the adult form of rickets that causes soft bones treatment with supplements will usually cure the condition. […] However, it may be several months before any bone pain and muscle weakness is relieved. […] You should continue taking vitamin D supplements regularly to prevent the condition returning.

• #1 Osteomalacia (Soft Bones) Symptoms, Causes & Treatment | Ada

  https://ada.com/conditions/osteomalacia/

  Osteomalacia is treatable, usually with vitamin and/or mineral supplements, and most people can be cured. It is generally treated by administration of vitamin D, calcium and, if needed, also phosphorus. […] If the osteomalacia is caused by an underlying condition, this will also need to be treated. Osteomalacia caused by phosphate deficiency is usually due to another condition. Treatment will be recommended by a doctor. […] Bone will begin to strengthen within a few weeks to a few months and should be fully healed within six months. However, pain and muscle weakness may continue to be experienced during the healing process. […] The amount of supplementary vitamin D a person may require depends on factors such as their age, how much natural sunlight they receive where they live and any possible other influencing factors, like having certain medical conditions or taking certain drugs that influence how the body takes up, processes or builds vitamin D.

• #1 Rickets: What It Is, Symptoms, and More

  https://www.verywellhealth.com/rickets-5080150

  The treatment depends on the type of rickets. […] In the case of rickets caused by a vitamin D deficiency, treatment can be as simple as upping your intake. […] Depending on the severity of the deficiency, a tailored and specific treatment plan can be pursued under the supervision of your healthcare provider. […] This will improve both the levels of vitamin D, as well as the body’s ability to absorb other essential nutrients for bone health. […] In the instance that the case of rickets disease is genetic, treatment is done through the oral consumption of phosphate in order to increase levels within the blood. […] It can also be helpful to take calcitriol, an active form of vitamin D, to help with the absorption of phosphate. […] Another medication has shown promise in the treatment of hereditary rickets. The drug in question is called Burosumab and was developed to address the symptoms and prevalence of the rare disease.

• #1 Osteomalacia (Soft Bones) Symptoms, Causes & Treatment | Ada

  https://ada.com/conditions/osteomalacia/

  If a person’s calcium intake from diet is less than 750 mg a day, supplements of 500-1000mg a day can help speed up the process of restoring bone. […] There are many things people can do in day-to-day life to promote healthy bones for osteomalacia prevention. These include: Having a diet rich in vitamin D, Getting a healthy amount of sun exposure, Reducing alcohol intake, Stopping smoking, Exercising regularly, Maintaining a healthy weight. […] Yes. Getting enough vitamin D, calcium and phosphorus, adapted to the special needs of someone with liver or kidney disease if necessary, will prevent osteomalacia.

• #1 Physiotherapy for Rickets and Osteomalacia | PPT

  https://www.slideshare.net/slideshow/physiotherapy-for-rickets-and-osteomalacia/238656721

  Rickets and osteomalacia are metabolic bone diseases caused by a deficiency of vitamin D or calcium. […] Physical therapy can help treat related impairments through exercises and manual techniques while ensuring medical management addresses the underlying deficiency. […] There are no direct physical therapy interventions for Rickets or Vitamin D deficiency. Patient will be referred to physical therapy for treatment of impairments such as decline in muscle strength, decline in physical functioning, or falls prevention. […] Physical therapy can help to also reduce any bone or muscle pain through stretching and strengthening exercises as well as hands on manual techniques. […] Physiotherapy plays an important role in a multidisciplinary approach to treatment. Tailored exercise programs are important to ensure strengthening of major muscle groups and improvement in ADL and social activities.

• #1 Physiotherapy for Rickets and Osteomalacia | PPT

  https://www.slideshare.net/slideshow/physiotherapy-for-rickets-and-osteomalacia/238656721

  Weight bearing exercises should be encouraged such as walking but not intensive or high impact exercises. […] Osteomalacia: Treatment o Calcium is given at 0. 5-3 gm/day, vitamin D 10,000 IU/day, and high protein diet. […] Physiotherapy plays an important role in a multidisciplinary approach to treatment.

• #2 Rickets and Osteomalacia: DIagnosis and Treatment

  https://www.massgeneral.org/children/rickets/diagnosis-and-treatment

  The most common treatment for rickets and osteomalacia includes a vitamin D supplement and dietary changes. Often, calcium supplements are also prescribed. In more serious cases, surgery or braces for the limbs can help with physical deformities. For patients with rare genetic conditions causing rickets and osteomalacia, specific targeted therapies are often available.

• #2 Nutritional rickets & osteomalacia: A practical approach to management

  https://pmc.ncbi.nlm.nih.gov/articles/PMC8061584/

  Defective mineralization of the growth plate and preformed osteoid result in rickets and osteomalacia, respectively. […] Treatment includes high-dose cholecalciferol or ergocalciferol daily for a minimum of 12 wk or stoss therapy in exceptional circumstances, each followed by lifelong maintenance supplementation. […] In addition, adequate calcium intake through diet or supplementation should be ensured. […] A practical approach to investigating and treating individuals suspected to have nutritional rickets and/or osteomalacia is outlined in the Table. […] Treatment of rickets incorporates treatment doses of vitamin D/calcium. […] Both D2 and D3 can be used for daily oral supplementation, however D3 is preferred for stoss therapy i.e., a single high-dose treatment, due to its longer half-life.

• #2 Nutritional Vitamin D deficiency rickets in children – Challenges in diagnosis, management, and prevention – Wadia Journal of Women and Child Health

  https://wjwch.com/nutritional-vitamin-d-deficiency-rickets-in-children-challenges-in-diagnosis-management-and-prevention/

  Nutritional rickets are characterized by under mineralization of the skeleton that leads to bone deformities and poor growth. […] The treatment of rickets requires Vitamin D therapy with adequate calcium supplementation. […] Both cholecalciferol and ergocalciferol may be used for treatment as they are efficacious and cost-effective instead of active Vitamin D preparations. […] Prolonged treatment with Vitamin D and calcium should be avoided for the risk of Vitamin D toxicity and nephrocalcinosis. […] Vitamin D treatment should be commenced in all children with nutritional rickets. […] The initial regimen consisted of bolus intramuscular dosing of 6 lac IU of cholecalciferol. […] Stoss therapy with a high bolus dose of Vitamin D ranging from 100,000 to 300,000 units can be administered to correct deficiency, especially in those where adherence to medication is of concern.

• #2 Frontiers | Diagnosis, treatment, and management of rickets: a position statement from the Bone and Mineral Metabolism Group of the Italian Society of Pediatric Endocrinology and Diabetology

  https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1383681/full

  Administration of a single-day high-dose of vitamin D therapy (stoss therapy), with doses reaching up to 600,000 IU, has been proposed. […] Daily treatment with vitamin D should be continued for 3-4 months, but the duration of treatment should be individualized. […] Patients experiencing symptomatic hypocalcemia, such as tetany, convulsions, or dilated cardiomyopathy, should receive intravenous calcium gluconate until serum calcium levels are normalized. […] Monitoring of treatment with vitamin D and calcium supplements varies with the severity of rickets and response to therapy. […] In order to prevent the resurgence of nutritional vitamin D deficiency rickets vitamin D supplementation should be continued. […] The recommended daily oral intake of calcium and phosphate varies between 150-220 mg/kg/day and 75-140 mg/kg/day through enteral feeds, respectively.

• #2 Nutritional rickets & osteomalacia: A practical approach to management – PubMed

  https://pubmed.ncbi.nlm.nih.gov/33380700/

  Defective mineralization of the growth plate and preformed osteoid result in rickets and osteomalacia, respectively. […] Treatment includes high-dose cholecalciferol or ergocalciferol daily for a minimum of 12 wk or stoss therapy in exceptional circumstances, each followed by lifelong maintenance supplementation. In addition, adequate calcium intake through diet or supplementation should be ensured. […] Preventative approaches should be tailored to the population needs and incorporate multiple strategies including targeted vitamin D supplementation of at-risk groups and food fortification with vitamin D and/or calcium. Economically, food fortification is certainly the most cost-effective way forward.

• #2 Osteomalacia and Rickets – almostadoctor

  https://almostadoctor.co.uk/encyclopedia/osteomalacia-and-rickets

  Osteomalacia and Rickets Treatment […] Vitamin D supplements + calcium are first line 400U tablets, 1-2 times/day. […] After 3 weeks, x-ray improvements can be seen. Typically starting at the very tip of the bone, and continuing down through the affected segment. […] Malabsorption might require calciferol (1,25(OH)2D) 1mg/day (equivalent to 40,000 units of Vit D!). […] Vit-D resistant rickets should be treated with calciferol 10,000 units/day. […] Renal osteomalacia is best treated with alfacalcidol. […] Hypercalcaemia is common with all vit D treatments, especially alfacalcidol.

• #2

  https://link.springer.com/article/10.1007/s00467-022-05505-5

  Here, we discuss the management of different forms of rickets, including new therapeutic approaches based on recent guidelines. Management includes close monitoring of growth, the degree of leg bowing, bone pain, serum phosphate, calcium, alkaline phosphatase as a surrogate marker of osteoblast activity and thus degree of rickets, parathyroid hormone, 25-hydroxyvitamin D3, and calciuria. An adequate calcium intake and normal 25-hydroxyvitamin D3 levels should be assured in all patients. Children with calcipenic rickets require the supplementation or pharmacological treatment with native or active vitamin D depending on the underlying pathophysiology. Treatment of phosphopenic rickets depends on the underlying pathophysiology. Fibroblast-growth factor 23 (FGF23)-associated hypophosphatemic rickets was historically treated with frequent doses of oral phosphate salts in combination with active vitamin D, whereas tumor-induced osteomalacia (TIO) should primarily undergo tumor resection, if possible. Burosumab, a fully humanized FGF23-antibody, was recently approved for treatment of X-linked hypophosphatemia (XLH) and TIO and shown to be superior for treatment of XLH compared to conventional treatment. Forms of hypophosphatemic rickets independent of FGF23 due to genetic defects of renal tubular phosphate reabsorption are treated with oral phosphate only, since they are associated with excessive 1,25-dihydroxyvitamin D production. Finally, forms of hypophosphatemic rickets caused by Fanconi syndrome, such as nephropathic cystinosis and Dent disease require disease-specific treatment in addition to phosphate supplements and active vitamin D. Adjustment of medication should be done with consideration of treatment-associated side effects, including diarrhea, gastrointestinal discomfort, hypercalciuria, secondary hyperparathyroidism, and development of nephrocalcinosis or nephrolithiasis.

• #2 Rickets and osteomalacia – Treatment | Health Information from Marsden Pharmacy

  https://marsdenpharmacy.co.uk/nhs_conditions_rickets-and-osteomalacia_treatment

  If your child has a bone deformity caused by rickets, such as bowed legs or curvature of the spine, your GP may suggest treatment to correct it. This may include surgery. […] A combination of phosphate supplements and a special form of vitamin D is required for the treatment of hypophosphatemic rickets, where a genetic defect causes abnormalities in the way the kidneys and bones deal with phosphate. […] Children with other types of genetic rickets need very large amounts of a special type of vitamin D treatment. […] If you have osteomalacia the adult form of rickets that causes soft bones treatment with supplements will usually cure the condition. […] However, it may be several months before any bone pain and muscle weakness is relieved. […] You should continue taking vitamin D supplements regularly to prevent the condition returning.

• #2 Osteomalacia | Causes, symptoms, treatment | Versus Arthritis

  https://versusarthritis.org/about-arthritis/conditions/osteomalacia/

  What treatments are there for osteomalacia? […] Treatment will cure osteomalacia in most cases, but easing bone pain, muscle weakness and cramps may take several months. […] If its caused by a lack of vitamin D, you will probably need to take vitamin D supplements every day. Taking calcium supplements every day too may speed up bone healing. […] You may need to take vitamin D supplements over a long period of time and if you stop taking them, the condition may return. […] Once you begin treatment for the condition any cracks in your bones will heal normally, though you may need painkillers in the meantime. You should avoid intensive exercise until the cracks have healed. […] People with kidney failure or inherited forms of osteomalacia often need lifelong support from their doctor. Theyll need to be monitored regularly in a hospital. They usually need special forms of vitamin D such as calcitriol tablets.

• #2

  https://journals.lww.com/ijmr/fulltext/2020/52040/nutritional_rickets___osteomalacia__a_practical.6.aspx

  Both D2 and D3 can be used for daily oral supplementation, however D3 is preferred for stoss therapy i.e., a single high-dose treatment, due to its longer half-life. […] A recent report of all the vitamin D supplements available in the Indian market highlighted the lack of suitable preparations. […] Dilated cardiomyopathy is generally treated with a combination of diuretics and angiotensin-converting enzyme inhibitors but must be managed in conjunction with a paediatric cardiologist.

• #2 Hypophosphatemic Rickets – Pediatrics – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/pediatrics/congenital-renal-transport-abnormalities/hypophosphatemic-rickets

  Treatment is oral phosphate plus calcitriol; burosumab is given for X-linked hypophosphatemia. […] Treatment of hypophosphatemic rickets consists of neutral phosphate solution or tablets. Phosphate supplementation lowers ionized calcium concentrations and further inhibits calcitriol conversion, leading to secondary hyperparathyroidism and exacerbating urinary phosphate wasting. Therefore, oral vitamin D is given as calcitriol. However, in HHRH or HHN (hypophosphatemia, hypercalcemia, and nephrocalcinosis), 1,25-dihydroxyvitamin D3 levels are elevated and dosing with calcitriol can be detrimental. […] Burosumab is an anti-FGF-23 monoclonal antibody that has become the treatment of choice for X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO) and has replaced the conventional therapy described above. The dose may be titrated upwards as needed to normalize serum phosphate. […] Treat with oral phosphate supplements and, except for HHRH and HHN (hypophosphatemia, hypercalcemia, and nephrocalcinosis), vitamin D (given as calcitriol). Use burosumab for appropriate patients with X-linked hypophosphatemia and tumor-induced osteomalacia.

• #2

  https://link.springer.com/article/10.1007/s00467-022-05505-5

  Treatment with phosphate should always be done in combination with active vitamin D (either with calcitriol or alphacalcidiol) in XLH patients, as this prevents the development of secondary hyperparathyroidism as seen in patients treated with phosphate salts alone, which further promotes renal phosphate wasting and can result in autonomous (tertiary) hyperparathyroidism. […] Treatment with active vitamin D also improves remineralization of the skeleton by enhancing vitamin D-dependent intestinal calcium and phosphate absorption. […] Burosumab has been approved by the European Medicines Agency (EMA), the US Food and Drug Administration (FDA), and Japanese health authorities for treatment of pediatric XLH patients aged above 12 months (6 months in the USA), showing radiographic evidence of bone disease and with growing skeletons.

• #2 FGF23-related hypophosphatemic rickets/osteomalacia: diagnosis and new treatment in: Journal of Molecular Endocrinology Volume 66 Issue 2 (2021)

  https://jme.bioscientifica.com/view/journals/jme/66/2/JME-20-0089.xml

  Because excessive actions of FGF23 are causing FGF23-related hypophosphatemic diseases such as XLH and TIO, the inhibition of FGF23 activities was considered to be a new candidate for the treatment of these diseases. FGF23 binds to Klotho/FGFR1 complex and activates intracellular signaling pathways including ERK. Therefore, the inhibition of FGF23 for the binding to Klotho/FGFR1 complex and inhibitors of FGFR or ERK pathway have been shown to suppress FGF23 actions and ameliorate hypophosphatemia in Hyp mice. In addition, antibodies to FGF23 were shown to improve hypophosphatemia, rickets and impaired mineralization of bone and increase grip power in Hyp mice. Based on these preclinical results, human MAB to FGF23, burosumab, has been developed as a new therapeutic agent for FGF23-related hypophosphatemic diseases.

• #2 FGF23-related hypophosphatemic rickets/osteomalacia: diagnosis and new treatment in: Journal of Molecular Endocrinology Volume 66 Issue 2 (2021)

  https://jme.bioscientifica.com/view/journals/jme/66/2/JME-20-0089.xml

  In a phase 1 clinical trial, single injection or infusion of burosumab increased serum phosphate and 1,25(OH)2D in a dose-dependent manner in 38 adult patients with XLH. Subsequent phase 1/2 study indicated that s.c. injections of burosumab every 4 weeks induced prolonged increase in serum phosphate and 1,25(OH)2D for more than 1 year in adult patients with XLH. Safety profiles were favorable and the most common drug-related adverse event was the injection site reaction. Phase 2 study in children with XLHR indicated that burosumab increased serum phosphate and 1,25(OH)2D and induced radiographic improvement of rickets. This study showed that every 2 weeks injections were more effective than every 4 weeks dosings in child patients. Phase 3 study in child patients indicated that burosumab was more effective than conventional therapy with phosphate and active vitamin D in increasing serum phosphate, TmP/GFR and 1,25(OH)2D, decreasing alkaline phosphatase, improving radiographic findings of rickets, and increasing recumbent length and standing height Z score. Phase 3 trial in adult patients with XLH indicated that burosumab improved bone mineralization, WOMAC physical function and stiffness scores, and induced fracture healing more effectively than placebo. Burosumab was also shown to increase serum phosphate and 1,25(OH)2D and improve osteomalacia in patients with TIO. From these results, burosumab was approved for patients with XLH or XLHR since 2018 in several countries including Europe and USA. The approval of burosumab is now expanding to other countries in Asia, South America and Middle East. The indication of burosumab is different depending on countries. In addition to XLH or XLHR, burosumab is approved for patients with TIO in several countries and for patients with FGF23-related hypophosphatemic diseases in Japan.

• #2 Clinical trial at IU School of Medicine improves treatment of genetic rickets

  https://medicine.iu.edu/news/2019/05/clinical-trial-at-iu-school-of-medicine-improves-treatment-of-genetic-rickets

  A new study shows a drug developed in conjunction with investigators at Indiana University School of Medicine to alleviate symptoms of a rare musculoskeletal condition is significantly more effective than conventional therapies. […] The primary outcome was improvement in rickets on X-rays, as scored by radiologists that were unaware of which treatment group the participant was in. […] By 40 weeks of treatment, researchers found 72 percent of the children who received Burosumab achieved substantial healing of rickets, while only 6 percent of those in the conventional therapy group saw substantial healing. […] This is the first study comparing Burosumab head-to-head with conventional therapy, said lead investigator Erik Imel, MD, associate professor of medicine at IU School of Medicine. We now know the magnitude of benefit from Burosumab over the prior approach with conventional therapy. This information is critical for doctors to make treatment decisions for patients with XLH. […] Researchers plan to continue studying the long-term effects of Burosumab, including the effect treating children has on height outcomes as an adult and whether this treatment will decrease the need for surgeries to correct bowed legs.

• #2

  https://journals.lww.com/ijmr/fulltext/2020/52040/nutritional_rickets___osteomalacia__a_practical.6.aspx

  Defective mineralization of the growth plate and preformed osteoid result in rickets and osteomalacia, respectively. […] Treatment includes high-dose cholecalciferol or ergocalciferol daily for a minimum of 12 wk or stoss therapy in exceptional circumstances, each followed by lifelong maintenance supplementation. […] A minimum of 12 wk treatment is recommended; nonetheless, the duration should be tailored to the individual based on the response to treatment. […] There is absolutely no role for phosphate supplements in the treatment of nutritional rickets; in fact, giving phosphate worsens secondary hyperparathyroidism. […] Reversal of secondary hyperparathyroidism with vitamin D-calcium supplementation improves serum phosphate levels. […] Treatment of rickets incorporates treatment doses of vitamin D-calcium.

• #2 Rickets | Better Health Channel

  https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/rickets

  Rickets is usually caused by a lack of vitamin D, calcium or phosphorus. […] Treatment options include improved sunlight exposure, diet, vitamin D and mineral supplements. […] Treatment options for rickets include: improved sunlight exposure, improved diet that includes adequate intake of calcium and vitamin D, oral vitamin D supplements these may need to be taken for about 3 months, special forms of vitamin D supplements for people whose bodies cant convert vitamin D into its active form, treatment for any underlying disorder, surgery to correct severe bone deformities. […] Bones that are poorly mineralised generally respond very quickly to dietary supplementation with calcium and vitamin D. Improvements may be seen on x-ray after only a few days of treatment. If rickets is treated when the child is young, there is a good chance that the skeletal deformities will disappear as the child matures. However, the deformities and reduced height will be permanent if the child goes through puberty without treatment.

• #2 Rickets: Definition, Symptoms, Causes & Treatment

  https://my.clevelandclinic.org/health/diseases/22459-rickets

  Surgery. Usually, your child’s bones will straighten out on their own. For especially severe cases, children may need to wear braces to help correct the bending of their bones. In some cases, surgery may also be an option. […] For inherited cases of rickets, there are several treatment options depending on the genetic disorder in question. Your pediatrician may refer you to see a specialist to help find a treatment solution.

• #2 Rickets: What It Is, Symptoms, and More

  https://www.verywellhealth.com/rickets-5080150

  The good news is that, although the symptoms can be debilitating and severe, they can be treated easily with the use of supplementation and a well-developed medical plan. […] The outlook when it comes to treating all forms of rickets is good, and many children with rickets can see a regression in both symptoms and bone deformities within three months of beginning their treatment plan. […] Although the effects of the disease can have a great negative impact on your day-to-day life, treatment is easily attainable and effective.

• #2 Osteomalacia (Soft Bones) Symptoms, Causes & Treatment | Ada

  https://ada.com/conditions/osteomalacia/

  If a person’s calcium intake from diet is less than 750 mg a day, supplements of 500-1000mg a day can help speed up the process of restoring bone. […] There are many things people can do in day-to-day life to promote healthy bones for osteomalacia prevention. These include: Having a diet rich in vitamin D, Getting a healthy amount of sun exposure, Reducing alcohol intake, Stopping smoking, Exercising regularly, Maintaining a healthy weight. […] Yes. Getting enough vitamin D, calcium and phosphorus, adapted to the special needs of someone with liver or kidney disease if necessary, will prevent osteomalacia.

• #2

• #2 Rickets: Not a Disease of the Past | AAFP

  https://www.aafp.org/pubs/afp/issues/2006/0815/p619.html

  With regard to nutritional rickets, the most important role of the primary care physician is helping parents prevent it. […] Because vitamin Ddependent rickets, type I is caused by lack of production of calcitriol, treatment requires the replacement of that active product. […] Familial hypophosphatemic rickets is treated with oral phosphorus and calcitriol (Rocaltrol), whereas hereditary hypophosphatemic rickets with hypercalciuria requires replacement of oral phosphorus alone. […] Investigators stress that treatment begun early in life lessens the disease burden.

• #3 Nutritional rickets & osteomalacia: A practical approach to management

  https://pmc.ncbi.nlm.nih.gov/articles/PMC8061584/

  Defective mineralization of the growth plate and preformed osteoid result in rickets and osteomalacia, respectively. […] Treatment includes high-dose cholecalciferol or ergocalciferol daily for a minimum of 12 wk or stoss therapy in exceptional circumstances, each followed by lifelong maintenance supplementation. […] In addition, adequate calcium intake through diet or supplementation should be ensured. […] A practical approach to investigating and treating individuals suspected to have nutritional rickets and/or osteomalacia is outlined in the Table. […] Treatment of rickets incorporates treatment doses of vitamin D/calcium. […] Both D2 and D3 can be used for daily oral supplementation, however D3 is preferred for stoss therapy i.e., a single high-dose treatment, due to its longer half-life.

• #3 FGF23-related hypophosphatemic rickets/osteomalacia: diagnosis and new treatment in: Journal of Molecular Endocrinology Volume 66 Issue 2 (2021)

  https://jme.bioscientifica.com/view/journals/jme/66/2/JME-20-0089.xml

  In a phase 1 clinical trial, single injection or infusion of burosumab increased serum phosphate and 1,25(OH)2D in a dose-dependent manner in 38 adult patients with XLH. Subsequent phase 1/2 study indicated that s.c. injections of burosumab every 4 weeks induced prolonged increase in serum phosphate and 1,25(OH)2D for more than 1 year in adult patients with XLH. Safety profiles were favorable and the most common drug-related adverse event was the injection site reaction. Phase 2 study in children with XLHR indicated that burosumab increased serum phosphate and 1,25(OH)2D and induced radiographic improvement of rickets. This study showed that every 2 weeks injections were more effective than every 4 weeks dosings in child patients. Phase 3 study in child patients indicated that burosumab was more effective than conventional therapy with phosphate and active vitamin D in increasing serum phosphate, TmP/GFR and 1,25(OH)2D, decreasing alkaline phosphatase, improving radiographic findings of rickets, and increasing recumbent length and standing height Z score. Phase 3 trial in adult patients with XLH indicated that burosumab improved bone mineralization, WOMAC physical function and stiffness scores, and induced fracture healing more effectively than placebo. Burosumab was also shown to increase serum phosphate and 1,25(OH)2D and improve osteomalacia in patients with TIO. From these results, burosumab was approved for patients with XLH or XLHR since 2018 in several countries including Europe and USA. The approval of burosumab is now expanding to other countries in Asia, South America and Middle East. The indication of burosumab is different depending on countries. In addition to XLH or XLHR, burosumab is approved for patients with TIO in several countries and for patients with FGF23-related hypophosphatemic diseases in Japan.

• #4

  https://journals.lww.com/ijmr/fulltext/2020/52040/nutritional_rickets___osteomalacia__a_practical.6.aspx

  Both D2 and D3 can be used for daily oral supplementation, however D3 is preferred for stoss therapy i.e., a single high-dose treatment, due to its longer half-life. […] A recent report of all the vitamin D supplements available in the Indian market highlighted the lack of suitable preparations. […] Dilated cardiomyopathy is generally treated with a combination of diuretics and angiotensin-converting enzyme inhibitors but must be managed in conjunction with a paediatric cardiologist.

Zobacz więcej